Aprea Therapeutics (APRE) Financials: Revenue & Earnings

APRE price $0.54 +0.03 +5.03%

Ticker
APRE
Price
$0.54
Change
+0.03 +5.03%
Market cap ?
$6.78M
P/E ?
-0.48
Dividend yield ?
0.00%
Beta ?
1.63
Sector
Healthcare
Industry
Biotechnology

Financials

201720182019202020212022202320242025
00000058323115025810

Aprea Therapeutics, Inc. is a biopharmaceutical company in its clinical development stage, dedicated to discovering and marketing innovative cancer treatments. Their therapeutic approach centers on modulating DNA damage response pathways. The company's primary drug candidate, ATRN-119, is an oral ATR inhibitor currently undergoing Phase 1/2a clinical trials for patients with advanced solid tumors. Beyond this lead…

Fair value

APRE fair value Not meaningful. Price $0.54.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare APRE

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.08—307.50K
2026-08-12-0.07-0.18—253.00K
2026-05-13-0.22-0.23140.50K—
2026-03-16-0.32-0.383.34K3.34K
2025-11-12-0.47-0.111.85K—
2025-08-12-0.53-0.77118.11K—
2025-05-14-0.66-0.65162.46K—
2025-03-25-0.49-0.69205.82K225.00K
2024-11-07-0.64-0.75354.62K225.00K
2024-08-12-0.58-0.64561.57K50.00K
2024-05-14-0.67-0.78380.57K—
2024-03-26-0.92-0.5614.07K110.00K
2023-11-09-0.86-1.08319.47K110.00K
2023-08-10-0.87-1.43249.69K—
2023-05-15-1.34-1.51——
2023-03-30-0.92-2.60——
2022-11-09-2.40-5.60——
2022-08-11-86.76-7.50——
2022-05-16-7.20-7.60——
2022-03-15-7.20-8.80——
2021-11-08-9.00-8.80——
2021-08-12-9.60-9.40——
2021-05-06-9.20-10.40——
2021-03-16-14.60-12.60——
2020-11-05-11.60-15.40——
2020-08-11-15.60-12.00——
2020-05-15-9.00-11.40——
2020-03-26-12.80-7.80——
2019-11-14-105.80-78.87——
2019-10-04-5.48———
2019-03-31-4.94———
2018-12-31-6.65———
2018-09-30-4.46———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-16Grissinger MichaelBuy12.55K$0.739.16K
2026-06-16Grissinger MichaelBuy3.13K——
2026-06-16Gruia GabrielaBuy12.55K$0.739.16K
2026-06-16Gruia GabrielaBuy3.13K——
2026-06-16Peters RichardBuy12.55K$0.739.16K
2026-06-16Peters RichardBuy3.13K——
2026-06-16HENNEMAN JOHN B IIIBuy3.13K——
2026-06-16HENNEMAN JOHN B IIIBuy12.55K$0.739.16K
2026-06-16BIZZARI JEAN-PIERREBuy12.55K$0.739.16K
2026-06-16BIZZARI JEAN-PIERREBuy3.13K——
2026-06-16Duey MarcBuy3.13K——
2026-06-16Duey MarcBuy12.55K$0.739.16K
2026-06-16Pamukcu RifatBuy12.55K$0.739.16K
2026-06-16Pamukcu RifatBuy3.13K——
2026-06-16Seizinger Bernd R.Buy3.13K——
2026-06-16Seizinger Bernd R.Buy12.55K$0.739.16K
2026-03-31Hamill John P.Buy30.98K$0.0031
2026-03-31Hamill John P.Buy30.98K$0.6821.16K
2026-03-31Peters RichardBuy123.92K$0.00124
2026-03-31Peters RichardBuy123.92K$0.6884.63K
2026-03-12Gilad OrenBuy20.18K——
2026-03-12Gilad OrenBuy80.70K$0.7761.74K
2026-03-12Hamill John P.Buy10.10K——
2026-03-12Hamill John P.Buy40.38K$0.7730.89K
2026-01-30Gilad OrenBuy28.10K$0.8925.01K
2026-01-30Gilad OrenBuy28.10K$0.7721.50K
2026-01-30Hamill John P.Buy5.70K$0.895.07K
2026-01-30Hamill John P.Buy5.70K$0.774.36K
2025-12-10Duey MarcBuy21.46K$1.1725.00K
2025-12-10Duey MarcBuy21.46K$1.0422.32K
2025-12-10Hamill John P.Buy5.00K$1.175.83K
2025-12-10Hamill John P.Buy5.00K$1.045.20K
2025-12-10Gilad OrenBuy21.46K$0.002
2025-12-10Gilad OrenBuy21.46K$1.0422.32K
2025-06-05Seizinger Bernd R.Buy1.04K——
2025-06-05Seizinger Bernd R.Buy4.18K$1.817.57K
2025-06-05Peters RichardBuy4.18K$1.817.57K
2025-06-05Peters RichardBuy1.04K——
2025-06-05Pamukcu RifatBuy1.04K——
2025-06-05Pamukcu RifatBuy4.18K$1.817.57K
2025-06-05HENNEMAN JOHN B IIIBuy1.04K——
2025-06-05HENNEMAN JOHN B IIIBuy4.18K$1.817.57K
2025-06-05Gruia GabrielaBuy4.18K$1.817.57K
2025-06-05Gruia GabrielaBuy1.04K——
2025-06-05Grissinger MichaelBuy4.18K$1.817.57K
2025-06-05Grissinger MichaelBuy1.04K——
2025-06-05Duey MarcBuy1.04K——
2025-06-05Duey MarcBuy4.18K$1.817.57K
2025-06-05BIZZARI JEAN-PIERREBuy4.18K$1.817.57K
2025-06-05BIZZARI JEAN-PIERREBuy1.04K——
2025-04-03Gilad OrenBuy2.50K$1.804.49K
2025-04-03Gilad OrenBuy3.00K$1.875.62K
2025-03-27Hamill John P.Buy3.37K——
2025-03-27Hamill John P.Buy13.46K$2.2029.61K
2025-03-27Gilad OrenBuy6.72K——
2025-03-27Gilad OrenBuy26.90K$2.2059.18K
2024-10-23Gilad OrenBuy500$3.921.96K
2024-10-18Duey MarcSell6.46K$4.5829.58K
2024-10-16Duey MarcBuy30.00K$4.39131.70K
2024-10-15Gilad OrenBuy250$2.90725
2024-10-14Duey MarcBuy190$2.58490
2024-10-14Gilad OrenBuy1.00K$2.592.59K
2024-10-11Hamill John P.Buy50$2.46123
2024-10-11Seizinger Bernd R.Buy10.00K$2.6826.80K
2024-10-10Gilad OrenBuy150$2.54381
2024-10-10Hamill John P.Buy450$2.611.17K
2024-06-20Seizinger Bernd R.Buy1.04K——
2024-06-20Seizinger Bernd R.Buy4.18K$4.0717.03K
2024-06-20Pamukcu RifatBuy1.04K——
2024-06-20Pamukcu RifatBuy4.18K$4.0717.03K
2024-06-20Peters RichardBuy4.18K$4.0717.03K
2024-06-20Peters RichardBuy1.04K——
2024-06-20HENNEMAN JOHN B IIIBuy1.04K——
2024-06-20HENNEMAN JOHN B IIIBuy4.18K$4.0717.03K
2024-06-20Grissinger MichaelBuy4.18K$4.0717.03K
2024-06-20Grissinger MichaelBuy1.04K——
2024-06-20Duey MarcBuy1.04K——
2024-06-20Duey MarcBuy4.18K$4.0717.03K
2024-05-01Mirza Nadeem Q.Buy26.92K$5.25141.33K
2024-05-01Mirza Nadeem Q.Buy6.73K——
2024-05-01Mirza Nadeem Q.Sell2.25K$7.8017.55K
2024-03-28Hamill John P.Buy3.37K——
2024-03-28Hamill John P.Buy13.46K$6.6990.05K
2024-03-28Gilad OrenBuy6.72K——
2024-03-28Gilad OrenBuy26.90K$6.69179.96K
2024-03-13Hamill John P.Buy1.01K$7.297.36K
2024-03-13Hamill John P.Buy505——
2024-03-13Hamill John P.Buy505——
2024-03-13Seizinger Bernd R.Buy6.86K$7.2950.01K
2024-03-13Seizinger Bernd R.Buy3.43K——
2024-03-13Seizinger Bernd R.Buy3.43K——
2024-03-13HENNEMAN JOHN B IIIBuy6.86K$7.2950.01K
2024-03-13HENNEMAN JOHN B IIIBuy3.43K——
2024-03-13HENNEMAN JOHN B IIIBuy3.43K——
2024-03-13Gilad OrenBuy2.00K$7.2914.58K
2024-03-13Gilad OrenBuy1.00K——
2024-03-13Gilad OrenBuy1.00K——
2023-08-23Pamukcu RifatBuy500——
2023-08-23Pamukcu RifatBuy2.00K$3.657.30K
2023-08-23Grissinger MichaelBuy2.00K$3.657.30K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 28, holders +6 vs prior quarter. Ownership 4.43%.

HolderSharesChangeChange %Value
AIGH CAPITAL MANAGEMENT LLC1.02M00.00%814.77K
VESTAL POINT CAPITAL, LP350.00K00.00%280.81K
SPHERA FUNDS MANAGEMENT LTD.270.00K00.00%216.62K
NANTAHALA CAPITAL MANAGEMENT, LLC205.76K00.00%165.08K
RENAISSANCE TECHNOLOGIES LLC105.80K80.70K+321.51%84.88K
GEODE CAPITAL MANAGEMENT, LLC74.87K-44.26K-37.15%60.07K
CITADEL ADVISORS LLC58.60K58.60KNew47.02K
BNP PARIBAS FINANCIAL MARKETS45.21K5.39K+13.55%36.27K
DIADEMA PARTNERS LP44.91K44.91KNew36.03K
VANGUARD FIDUCIARY TRUST CO38.46K00.00%30.85K
SUSQUEHANNA INTERNATIONAL GROUP, LLP34.94K21.92K+168.39%28.03K
MORGAN STANLEY25.83K3.50K+15.67%20.72K
VANGUARD CAPITAL MANAGEMENT LLC22.88K3.26K+16.61%18.35K
LPL FINANCIAL LLC16.05K-5.00K-23.75%12.88K
HIGHTOWER ADVISORS, LLC13.86K00.00%11.12K
NORTHERN TRUST CORP13.71K13.71KNew11.00K
PERSISTENT ASSET PARTNERS LTD11.49K11.49KNew9.22K
XTX TOPCO LTD10.56K10.56KNew8.48K
BLACKROCK, INC.7.17K-1.33K-15.65%5.75K
TOWER RESEARCH CAPITAL LLC (TRC)3.59K-1.54K-29.98%2.88K
GROUP ONE TRADING LLC57700.00%463
BARCLAYS PLC473473New379
OSAIC HOLDINGS, INC.29500.00%236
WEALTHCOLLAB, LLC15800.00%127
FMR LLC4545New36

Earnings and financials

Aprea Therapeutics, Inc. (APRE) trades at $0.54, with a market cap of $6.78M and a trailing P/E of -0.48. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

201720182019202020212022202320242025
00000058323115025810

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Aprea Therapeutics (APRE) Financials: Revenue & Earnings

APRE$0.54+0.03 +5.03%

$6.78M

Market Cap

-0.48

P/E

—

Forward P/E

—

Score

Price History